These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 10786691)

  • 1. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
    Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
    Boudjelal M; Voorhees JJ; Fisher GJ
    Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells.
    Tanaka T; Rodríguez de la Concepción ML; De Luca LM
    Biochem Pharmacol; 2001 Jun; 61(11):1347-55. PubMed ID: 11331070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
    Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
    Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway.
    Kopf E; Plassat JL; Vivat V; de Thé H; Chambon P; Rochette-Egly C
    J Biol Chem; 2000 Oct; 275(43):33280-8. PubMed ID: 10869350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
    Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
    J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of UV irradiation on nuclear retinoid receptor levels in cultured keratinocytes and melanocytes.
    Andersson E; Rosdahl I; Törmä H; Vahlquist A
    Exp Dermatol; 2003 Oct; 12(5):563-71. PubMed ID: 14705796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
    Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
    Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.
    Ye XF; Liu S; Wu Q; Lin XF; Zhang B; Wu JF; Zhang MQ; Su WJ
    World J Gastroenterol; 2003 Sep; 9(9):1915-9. PubMed ID: 12970875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways.
    Karlsson T; Vahlquist A; Törmä H
    J Dermatol Sci; 2010 Mar; 57(3):207-13. PubMed ID: 20122816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif.
    Spencer ML; Theodosiou M; Noonan DJ
    J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes.
    Yamaguchi S; Murata Y; Nagaya T; Hayashi Y; Ohmori S; Nimura Y; Seo H
    J Mol Endocrinol; 1999 Feb; 22(1):81-90. PubMed ID: 9924183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes.
    Bulteau AL; Moreau M; Nizard C; Friguet B
    Free Radic Biol Med; 2002 Jun; 32(11):1157-70. PubMed ID: 12031900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
    Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma.
    Adachi S; Okuno M; Matsushima-Nishiwaki R; Takano Y; Kojima S; Friedman SL; Moriwaki H; Okano Y
    Hepatology; 2002 Feb; 35(2):332-40. PubMed ID: 11826406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.